BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16123308)

  • 1. An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition.
    Ong JC; Brody SA; Large CH; Geyer MA
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1163-71. PubMed ID: 16123308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice.
    Brody SA; Geyer MA; Large CH
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):240-6. PubMed ID: 12698229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice.
    Umeda K; Suemaru K; Todo N; Egashira N; Mishima K; Iwasaki K; Fujiwara M; Araki H
    Eur J Pharmacol; 2006 Dec; 553(1-3):157-62. PubMed ID: 17070517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate improves prepulse inhibition deficits induced by corticotropin-releasing factor independent of GABA(A) and GABA(B) receptor activation.
    Douma TN; Millan MJ; Verdouw PM; Oosting RS; Olivier B; Groenink L
    Neuropharmacology; 2014 Apr; 79():66-74. PubMed ID: 24211652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood stabilizers increase prepulse inhibition in DBA/2NCrl mice.
    Flood DG; Choinski M; Marino MJ; Gasior M
    Psychopharmacology (Berl); 2009 Aug; 205(3):369-77. PubMed ID: 19404613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect.
    Mann L; Heldman E; Bersudsky Y; Vatner SF; Ishikawa Y; Almog O; Belmaker RH; Agam G
    Bipolar Disord; 2009 Dec; 11(8):885-96. PubMed ID: 19922557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice.
    Brody SA; Conquet F; Geyer MA
    Psychopharmacology (Berl); 2004 Mar; 172(2):187-95. PubMed ID: 14615875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania.
    Frey BN; Andreazza AC; Rosa AR; Martins MR; Valvassori SS; Réus GZ; Hatch JP; Quevedo J; Kapczinski F
    Behav Pharmacol; 2006 Jun; 17(4):311-8. PubMed ID: 16914949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amphetamine-chlordiazepoxide mixture, a pharmacological screen for mood stabilizers, does not enhance amphetamine-induced disruption of prepulse inhibition.
    Douma TN; Kolarz A; Postma Y; Olivier B; Groenink L
    Behav Brain Res; 2011 Nov; 225(1):377-81. PubMed ID: 21820012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.
    Semenova S; Geyer MA; Sutcliffe JG; Markou A; Hedlund PB
    Biol Psychiatry; 2008 Jan; 63(1):98-105. PubMed ID: 17531208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents.
    Douma TN; Millan MJ; Boulay D; Griebel G; Verdouw PM; Westphal KG; Olivier B; Groenink L
    Psychopharmacology (Berl); 2014 Apr; 231(7):1289-303. PubMed ID: 24186076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania.
    Corrêa C; Amboni G; Assis LC; Martins MR; Kapczinski F; Streck EL; Quevedo J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):887-91. PubMed ID: 17367908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.
    Frey BN; Valvassori SS; Réus GZ; Martins MR; Petronilho FC; Bardini K; Dal-Pizzol F; Kapczinski F; Quevedo J
    J Psychiatry Neurosci; 2006 Sep; 31(5):326-32. PubMed ID: 16951735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute ethanol or amphetamine administration on the acoustic startle response and prepulse inhibition in adolescent and adult rats.
    Brunell SC; Spear LP
    Psychopharmacology (Berl); 2006 Jul; 186(4):579-86. PubMed ID: 16758242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine.
    Levin R; Calzavara MB; Santos CM; Medrano WA; Niigaki ST; Abílio VC
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1748-52. PubMed ID: 21693159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania.
    Arban R; Maraia G; Brackenborough K; Winyard L; Wilson A; Gerrard P; Large C
    Behav Brain Res; 2005 Mar; 158(1):123-32. PubMed ID: 15680200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
    Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 50-kHz ultrasonic vocalizations in animal models of mania: Ketamine and lisdexamfetamine-induced hyperlocomotion in rats.
    Wendler E; de Souza CP; Vecchia DD; Kanazawa LKS; de Almeida Soares Hocayen P; Wöhr M; Schwarting RKW; Andreatini R
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):1900-1908. PubMed ID: 27842942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.